HKB's Mouse Myasthenia Gravis Models provide pharmaceutical researchers with robust platforms for investigating this antibody-mediated autoimmune disorder affecting neuromuscular transmission. Our validated rodent models include experimental autoimmune MG (EAMG) induced by acetylcholine receptor immunization and passive transfer models.